INTERNAL MEDICINE - PEDIATRICS
|
|
- Daniela Tyler
- 5 years ago
- Views:
Transcription
1 Rev. Med. Chir. Soc. Med. Nat., Iaşi 2014 vol. 118, no. 4 INTERNAL MEDICINE - PEDIATRICS UPDATES METABOLIC SYNDROME A WIDESPREAD THREATENING CONDI- TION; RISK FACTORS, DIAGNOSTIC CRITERIA, THERAPEUTIC OP- TIONS, PREVENTION AND CONTROVERSIES: AN OVERVIEW Ioana Cristina Amihăesei, Liliana Chelaru University of Medicine and Pharmacy Grigore T. Popa - Iaşi Faculty of Medicine Department of Morpho-Functional Sciences METABOLIC SYNDROME A WIDESPREAD THREATENING CONDITION; RISK FAC- TORS, DIAGNOSTIC CRITERIA, THERAPEUTIC OPTIONS, PREVENTION AND CON- TROVERSIES: AN OVERVIEW (Abstract): Metabolic syndrome diagnostic criteria include at least three of five of the following medical conditions: abdominal obesity, high blood pressure, abnormal high fasting plasma glucose, elevated serum triglycerides and low HDL (high density cholesterol) level. Sedentary, overweight and obesity are characteristically associated with the syndrome, nevertheless there are new studies which indicate that chronic stress, through deregulation of the hypothalamic-pituitary-adrenal (HPA) axis is also involved in the development of the syndrome. Metabolic syndrome represents a significant risk for the development of the cardiovascular diseases. New studies in the USA have estimated its prevalence at approximately 34 % of the adult population and its prevalence is increasing with age. Diagnosis guidelines are establishing the metabolic syndrome diagnostic when are met three of the following five conditions: fasting glucose 100 mg/dl or type 2 diabetes receiving drug therapy for hyperglycemia; high blood pressure 130/85 mm Hg or high blood pressure receiving drug therapy; triglycerides 150 mg/dl or treatment for plasma hyper-triglyceride value; HDL-C < 40 mg/dl in men and < 50 mg/dl in women or if under therapy for reduced HDL-C levels and waist circumference of 102 cm in men and 88 cm in women. Besides important change of lifestyle, often drug therapy is needed (diuretics and ACE inhibitors, cholesterol drugs and weight loss medications). The value of physical activity and diet in prevention and treatment of the syndrome is supported by numerous studies. Association of metabolic syndrome and card i- ovascular risk is still a matter of controversy, in what concerns the lack of significant cardiovascular risk in the case of obesity itself without metabolic syndrome. Keywords: METABOL- IC SYNDROME, OBESITY, HPA (HYPOTHALAMIC-PITUITARY-ADRENAL) AXIS, HDL CHOLESTEROL, LDL CHOLESTEROL Metabolic syndrome is a disorder affecting the energy use and storage. Criteria needed for diagnosis are including at least five of the following medical conditions: abdominal obesity, high blood pressure, abnormal high fasting plasma glucose, elevated serum triglycerides and low HDL (high density cholesterol) level. Metabolic syndrome represents a significant risk for the development of cardiovascular diseases and diabetes. Different studies have estimated the prevalence of the syndrome in the USA at approximately 34 % of the adult population (1, 2). 896
2 Metabolic syndrome a widespread threatening condition; risk factors, diagnostic criteria, therapeutic options, prevention and controversies: an overview Metabolic syndrome is also known as: insulin resistance syndrome, syndrome x, metabolic syndrome x, cardio metabolic syndrome. The term of metabolic syndrome was first used in the late 1950 s and became commonly used at the end of 1970 s, first to describe association of risk factors for diabetes (3). In 1947 it was first noticed that the upper body obesity was predisposing to diabetes, atherosclerosis and gout. In 1977 was used the term of metabolic syndrome to describe the association between obesity, diabetes mellitus, hyper-lipoproteinemia, hyperuricemia and hepatic steatosis and thus to contour the risk factors for atherosclerosis (2, 4). RISK FACTORS New researches are indicating that chronic stress is involved in the development of the metabolic syndrome, by disruption of the hormonal balance of the hypothalamic-pituitary-adrenal axis (HPA-axis). Disruption of HPA-axis induces increased circulatory cortisol levels with consequently high glucose and insulin levels, finally leading to insulin-triggered effects on adipose tissue and resulting into visceral adiposity, insulin resistance, dyslipidemia, high blood pressure and effects on bone metabolism, with the development of low turnover osteoporosis. Disruption in the functioning of HPA-axis is explaining the involvement of the abdominal obesity in the development of the cardiovascular disease, type 2 -diabetes and stroke (5). Overweight and obesity is the main characteristic of the syndrome, reflected in the strong link between its prevalence and waist circumference, associated with increasing adipose mass. Nevertheless, there are cases which show normal weight but do have the syndrome (6). Sedentary behavior is one of the main risk factors for cardiovascular diseases and mortality. Most of the metabolic syndrome s features are associated with sedentarism: increased abdominal adipose tissue, low HDL cholesterol level, high blood pressure, high glucose levels (7). Metabolic syndrome affects 44 % of the US population over 50 years of age. The syndrome is more frequent in female sex and its prevalence is increasing with age, all over the world. Metabolic syndrome is increasing five folds the risk of type 2 diabetes mellitus, which is seen like a complication of the syndrome. It is believed that pre diabetes and metabolic syndrome are representing in fact the same disorder, but defined by different sets of biological markers. Metabolic syndrome is associated with a higher risk for cardiovascular disease, than the cases with type 2 diabetes mellitus without associated metabolic syndrome. Hypoadiponectinemia is increasing insulin resistance and it represents also a risk factor for the development of the metabolic syndrome. Patients with schizophrenia and other psychiatric diseases are at high risk for metabolic syndrome, a risk which is increased in such cases by sedentary behavior, noxious dietary habits and antipsychotic drug induced adverse effects. 32 to 51 % of individuals with psychiatric disorders have metabolic syndrome, with a higher prevalence in women than in men (2, 8). Common triggers, such as excessive sugar intake and generally overabundant food environment are incriminated in the concomitant development of multiple metabolic abnormalities at the same time, pointing once more the dysfunction of energy use and storage paths in the metabolic syndrome (8, 9, 10). 897
3 Ioana Cristina Amihăesei, Liliana Chelaru Markers of systemic inflammation, such as C-reactive protein, fibrinogen, interleukin 6, tumor necrosis factor alpha (TNF-α) are increased in the metabolic syndrome. TNF-α is causing the production of inflammatory cytokines and is inducing cell signaling through interaction with TNF-α receptor, which may lead to insulin resistance. Increase of adipose tissue is increasing the number of immune cells inside it, cells which are involved in the chronic inflammatory processes; chronic inflammation being a risk factor for the development of arterial hypertension, atherosclerosis and diabetes (11). DIAGNOSTIC CRITERIA Main symptom of metabolic syndrome is the central obesity (also-known as visceral, male-pattern or apple-shaped adiposity) an overweight with accumulation of adipose tissue mainly around the waist and trunk (6). Signs of metabolic syndrome include: high blood pressure, decreased fasting serum HDL cholesterol, elevated fasting serum triglyceride level (VLDL triglyceride), impaired fasting-glucose level and insulin resistance. Metabolic syndrome is usually associated with hyperuricemia, hepatic steatosis, polycystic ovarian syndrome in women and erectile dysfunction in men, and acanthosis nigricans, xanthomas or xanthelasmas, in patients with severe dyslipidemia (12). The diagnosis guidelines from National Heart, Lung and Blood Institute (NHLBI) and the American Heart Association (AHA) are stipulating that the diagnosis of metabolic syndrome is established, when are met three of the following five conditions (13): - fasting glucose 100 mg/dl or type 2 diabetes which is receiving drug therapy for hyperglycemia; - blood pressure 130/85 mmhg or high blood pressure which is under drug therapy; - triglycerides 150 mg/dl or if treated for hypertriglyceridemia; - HDL-cholesterol < 40 mg/dl in men and < 50 mg/dl in women, or if under therapy for reduced HDL-cholesterol; - waist circumference 102 cm in men, or 88 cm in women. Complaints of chest pain, dyspnea or claudication are frequent symptoms of potential complications. Obstructive sleep apnea seems to be a novel risk factor for metabolic syndrome (14). A matter of controversy is represented by the fact that adipose tissue and resulted obesity are generally explaining most of the cardiovascular risk. Nevertheless, obesity itself, without metabolic syndrome is not associated with a significant cardiovascular risk, while metabolic syndrome without obesity is associated with a significant risk of cardiovascular disease and diabetes. Generalized lipodistrophy characterized by an almost complete absence of adipose tissue develops signs of metabolic syndrome in the absence of adipose tissue, resulting in type 2 diabetes. Type 2 diabetes is cured if in transgenic mice with lipodistrophy, adipose tissue is transplanted (15, 16). THERAPEUTIC OPTIONS AND PREVENTION Change of lifestyle is the first choice treatment of the metabolic syndrome. If the efforts of reversing the risk factors are not giving expected results in 3 to 6 months, then drug therapy is needed. Diuretics and ACE inhibitors are used to treat arterial hypertension. Cholesterol drugs are used to 898
4 Metabolic syndrome a widespread threatening condition; risk factors, diagnostic criteria, therapeutic options, prevention and controversies: an overview reduce LDL cholesterol and triglycerides elevated levels and to increase HDL low levels. Sometimes are used weight loss medications, which may result in weight loss. As obesity is generally considered the main feature of the syndrome which is leading to the development of the other symptoms, weight loss as well as lifestyle changes, including diet and physical activity, may reduce the need for medications. Many studies are supporting the value of physical activity and diet in the therapy of the metabolic syndrome. Restriction of the total dietary carbohydrate intake shows most efficiency in decreasing common manifestations of the metabolic syndrome. Unfortunately, high-dose statins therapy has been resulted in rapid progression to diabetes (17). Different strategies are used to prevent the development of the metabolic syndrome, like increased physical activity (for example walking 30 minutes daily) and low caloric diet. International Obesity Task force is supporting the idea of a need for sociopolitical measures to decrease the rate of metabolic syndrome development in population. Caerphilly Heart Disease Study which followed 2375 male subjects over 20 years suggested that daily intake of approximately 568 ml of milk or correspondent dairy derivatives reduced with more than 50 % the risk of metabolic syndrome. There are studies which support these findings, while others are questioning them (7, 18, 19). REFERENCES 1. Ford ES, Gilles WH, Dietz WH. Prevalence of metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287(3): Vancampfort D, Corell CU, Wampers M, Sienaert P, Mitchell AJ. Metabolic Syndrome and metabolic abnormalities in patients with major depressive disorder: a meta-analysis of prevalences and moderating variables. Psychol Med 2013; 21: Katzmaryk PT, Leon AS, Wilmore JH, Skinner JS, Rao DC. Targeting The Metabolic Syndrome with Exercise Evidence from the HERITAGE Family Study. Med Sci Sports Exerc 2007; 35 (10): Bremer AA, Mietns-Synder M, Lustig RH. Toward a unifying hypothesis of metabolic syndrome. Pediatrics 2012; 129(3): Rosmond R, Björntor P. The hypothalamic-pituitary-adrenal axis activity as a predictor of cardiovascular disease, type 2 diabetes and stroke. J Intern Med 2000; 247(2): Lara-Castro C, Fu Y, Chung BH, Garvey WT. Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease. Curr Opin in Lipidology 2007; 18(3): Lakka TA, Laaksonen DE. Physical activity in prevention and treatment of the metabolic syndrome. Physiologie appliqué, nutrition et metabolisme 2007; 32 (1): Narasimhan M, Raynor JD. Evidence-based perspective on metabolic syndrome and use of antipsychotics. Drug Benefits Trends 2010; 22: Edwardson CL, Gorely T, Davies MJ, Gray LJ. Association of sedentary behavior with metabolic syndrome: a meta-analysis. PLoS One 2012; 7(4): e Prollex RL, Hegele RA. Genetic determinants of the metabolic syndrome. Nat Clin Pract Cardiovasc Med 2006; 3(9): Page M, Clarke P. Adrenocortical, autonomic and inflammatory causes of the metabolic syndrome: nested case-control study. Circulation 2002; 106(21): Phillips GB. Sex hormones, risk factors and cardiovascular disease. Am J Med 1978; 65(1):
5 Ioana Cristina Amihăesei, Liliana Chelaru 13. Alberti KG, Eckel RH, Grundy SM, Zimonet PZ, Cleeman JI. International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of obesity: Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention, National Heart, Lung and Blood Institute, American Heart Association, World Heart Federation, International Atherosclerosis Society and International Association for the Study of Obesity. Circulation 2009; 120 (16): Farooqui AA, Farooqui P, Panza F, Frisardi V. Metabolic syndrome a risk factor for neurologic disorders. Cell Mol Life Sci 2012; 69(5): Fukuchi S, Hamaguchi K, Seike M, Himeno K, Sakata T. Role of Fatty Acid Composition in the Development of Metabolic Disorders in Sucrose-Induced Obese Rats. Exp Biol Med 2004; 229(6): Kahn R. Metabolic syndrome what is the clinical usefulness? Lancet 2008; 371(9628): Volek JS, Feinnman RD. Carbohydrate restriction improves the features of Metabolic Syndrome: Metabolic Syndrome may be defined by the response to carbohydrate restriction. Nutr Metab (Lond) 2005; 2(10: James PT, Rigby N, Leach R. The obesity epidemic, metabolic syndrome and future prevention strategies. Eur J Cardiovasc Prev Rehabil 2004; 11(1): Snijder BJ, van der Heijden AA, van Dam RM. Is higher dairy consumption associated with lower body weight and fewer metabolic disturbances? The Hoom Study. Am J Clin Nutr 2007; 85(4): NOUTĂȚI NEWS ONCOPLASTIC MAMMOPLASTY ASSOCIATED WITH POSTMASTECTOMY RADIA- TION THERAPY: THE PLAN FOR REDUCING RECONSTRUCTIVE COMPLICATIONS It is widely accepted that breast cancer patients who require radiation therapy after maste c- tomy and immediate reconstruction treatment, suffer high complication rates. A group of r e- searchers from University of California showed that combining neo-adjuvant chemotherapy with oncoplastic mammoplasty is one of the best solutions for high aesthetics results with low local recurrence rates for patients needing radiotherapy treatment after surgery. 64 p a- tients mastectomized with immediate reconstruction were compared with 37 who underwent the new procedure. After using the Fisher s exact test, the results showed rates of complications for infection 16.2% versus 35.9% (p < 0.04), for skin flap necrosis 10.8% versus 29.7% (p < 0.05) and for unplanned intervention 2.7% versus 37.5% (p < 0.001), much higher for the mastectomy group (excepting seroma 7.8% versus 5.4%, p = 0.6). The authors show that oncoplastic mammoplasty is highly recommended to patients with local tumor in advanced stages, in order to avoid complications of multiple long lasting surgical procedures, improving quality of our patients life. (Peled AW, Sbitany H, Foster RD, Esserman LJ. Oncoplastic mammoplasty as a strategy for reducing reconstructive complications associated with postmastectomy radiation therapy. Breast J 2014; 20(3):302-7) Ioannis Gardikiotis 900
Metabolic syndrome. Metabolic syndrome and prediabetes appear to be the same disorder, just diagnosed by a different set of biomarkers.
Metabolic syndrome Metabolic syndrome is a disorder of energy utilization and storage, diagnosed by a co-occurrence of three out of five of the following medical conditions: abdominal (central) obesity,
More informationMETABOLIC SYNDROME IN OBESE CHILDREN AND ADOLESCENTS
Rev. Med. Chir. Soc. Med. Nat., Iaşi 2012 vol. 116, no. 4 INTERNAL MEDICINE - PEDIATRICS ORIGINAL PAPERS METABOLIC SYNDROME IN OBESE CHILDREN AND ADOLESCENTS Ana-Maria Pelin 1, Silvia Mǎtǎsaru 2 University
More informationThe Metabolic Syndrome Update The Metabolic Syndrome: Overview. Global Cardiometabolic Risk
Update 2013 Marc Cornier, M.D. Associate Professor of Medicine Division of Endocrinology, Metabolism & Diabetes Anschutz Health and Wellness Center University of Colorado School of Medicine Denver Health
More information3/20/2011. Body Mass Index (kg/[m 2 ]) Age at Issue (*BMI > 30, or ~ 30 lbs overweight for 5 4 woman) Mokdad A.H.
U.S. Adults: 1988 Nineteen states with 10-14% 14% Prevalence of Obesity (*BMI > 30, or ~ 30 lbs overweight for 5 4 woman) Metabolic John P. Cello, MD Professor of Medicine and Surgery, University of California,
More informationHSN301 REVISION NOTES TOPIC 1 METABOLIC SYNDROME
HSN301 REVISION NOTES TOPIC 1 METABOLIC SYNDROME What does the term Metabolic Syndrome describe? Metabolic syndrome describes a cluster of cardio-metabolic conditions that increase one's risk of developing
More informationMetabolic Syndrome: What s in a name?
Commentary Metabolic Syndrome: What s in a name? Deborah P. Wubben, MD, MPH; Alexandra K. Adams, MD, PhD Abstract The term metabolic syndrome has recently become en vogue. But is the definition realistic,
More informationMetabolic Syndrome. DOPE amines COGS 163
Metabolic Syndrome DOPE amines COGS 163 Overview - M etabolic Syndrome - General definition and criteria - Importance of diagnosis - Glucose Homeostasis - Type 2 Diabetes Mellitus - Insulin Resistance
More informationMetabolic Syndrome: An overview. Kevin Niswender MD, PhD Vanderbilt University School of Medicine
Metabolic Syndrome: An overview. Kevin Niswender MD, PhD Vanderbilt University School of Medicine Setting the scene GB, 43 yo AA man followed for hypothyroidism returns on LT4 125 mcg/d and has a TSH=1.1
More informationRick Fox M.A Health and Wellness Specialist
Metabolic Diseases Rick Fox M.A Health and Wellness Specialist Metabolic Diseases Metabolism is the process your body uses to get or make energy from the food you eat. Food is made up of proteins, carbohydrates
More informationOBESITY IN PRIMARY CARE
OBESITY IN PRIMARY CARE Obesity- definition Is a chronic disease In ICD 10 E66 Overweight and obesity are defined as abnormal or excessive fat accumulation that may impair health. Obesity is a leading
More informationMetabolic Syndrome Update The Metabolic Syndrome: Overview. Global Cardiometabolic Risk
Metabolic Syndrome Update 21 Marc Cornier, M.D. Associate Professor of Medicine Division of Endocrinology, Metabolism & Diabetes University of Colorado Denver Denver Health Medical Center The Metabolic
More informationMetabolic Syndrome. Bill Roberts, M.D., Ph.D. Professor of Pathology University of Utah
Metabolic Syndrome Bill Roberts, M.D., Ph.D. Professor of Pathology University of Utah Objectives Be able to outline the pathophysiology of the metabolic syndrome Be able to list diagnostic criteria for
More informationMetabolic Syndrome. Shon Meek MD, PhD Mayo Clinic Florida Endocrinology
Metabolic Syndrome Shon Meek MD, PhD Mayo Clinic Florida Endocrinology Disclosure No conflict of interest No financial disclosure Does This Patient Have Metabolic Syndrome? 1. Yes 2. No Does This Patient
More informationMetabolic Syndrome.
www.bmiweightloss.com.au What is the metabolic syndrome? The was first described in 1988 by Gerald Reavson It was originally described as the clustering of four conditions These conditions when present
More informationObjectives. Objectives. Alejandro J. de la Torre, MD Cook Children s Hospital May 30, 2015
Alejandro J. de la Torre, MD Cook Children s Hospital May 30, 2015 Presentation downloaded from http://ce.unthsc.edu Objectives Understand that the obesity epidemic is also affecting children and adolescents
More informationZia H Shah MD FCCP. Director of Sleep Lab Our Lady Of Lourdes Hospital, Binghamton
Zia H Shah MD FCCP Director of Sleep Lab Our Lady Of Lourdes Hospital, Binghamton Obesity 70-80% of cases Alcohol use Hypognathism Marfan s syndrome Smoking ENT problems OSA and DM epidemics have
More informationCardiovascular Complications of Diabetes
VBWG Cardiovascular Complications of Diabetes Nicola Abate, M.D., F.N.L.A. Professor and Chief Division of Endocrinology and Metabolism The University of Texas Medical Branch Galveston, Texas Coronary
More informationJMSCR Volume 03 Issue 04 Page April 2015
www.jmscr.igmpublication.org Impact Factor 3.79 ISSN (e)-2347-176x Study of Metabolic Syndrome and Thyroid Dysfunction Authors Dr. Nalini R Humaney, Dr. Saurabh Ashok Lande, Dr. Ramesh P Mundle N.K.P.Salve
More informationThe Metabolic Syndrome Update The Metabolic Syndrome Update. Global Cardiometabolic Risk
The Metabolic Syndrome Update 2018 Marc Cornier, M.D. Professor of Medicine Division of Endocrinology, Metabolism & Diabetes Anschutz Health and Wellness Center University of Colorado School of Medicine
More informationMetabolic Syndrome among Type-2 Diabetic Patients in Benghazi- Libya: A pilot study. Arab Medical University. Benghazi, Libya
Original Article Metabolic Syndrome among Type-2 Diabetic Patients in Benghazi- Libya: A pilot study Alshkri MM 1, Elmehdawi RR 2 1 Benghazi Diabetes Center. 2 Medical Department, Faculty of Medicine,
More informationEstablished Risk Factors for Coronary Heart Disease (CHD)
Getting Patients to Make Small Lifestyle Changes That Result in SIGNIFICANT Improvements in Health - Prevention of Diabetes and Obesity for Better Health Maureen E. Mays, MD, MS, FACC Director ~ Portland
More informationDiabetes Day for Primary Care Clinicians Advances in Diabetes Care
Diabetes Day for Primary Care Clinicians Advances in Diabetes Care Elliot Sternthal, MD, FACP, FACE Chair New England AACE Diabetes Day Planning Committee Welcome and Introduction This presentation will:
More informationMetabolic Syndrome: Why Should We Look For It?
021-CardioCase 29/05/06 15:04 Page 21 Metabolic Syndrome: Why Should We Look For It? Dafna Rippel, MD, MHA and Andrew Ignaszewski, MD, FRCPC CardioCase presentation Andy s fatigue Andy, 47, comes to you
More informationObesity, Metabolic Syndrome, and Diabetes: Making the Connections
Obesity, Metabolic Syndrome, and Diabetes: Making the Connections Alka M. Kanaya, M.D. Associate Professor of Medicine & Epi/Biostats University of California, San Francisco February 26, 21 Roadmap 1.
More information8/15/2018. Promoting Education, Referral and Treatment for Patients Presenting with Metabolic Syndrome. Metabolic Syndrome.
Promoting Education, Referral and Treatment for Patients Presenting with Metabolic Syndrome Diagnostic Criteria (3/5) Metabolic Syndrome Key Facts JAN BRIONES DNP, APRN, CNP FAMILY NURSE PRACTITIONER Abdominal
More informationObesity and the Metabolic Syndrome in Developing Countries: Focus on South Asians
Obesity and the Metabolic Syndrome in Developing Countries: Focus on South Asians Anoop Misra Developing countries, particularly South Asian countries, are witnessing a rapid increase in type 2 diabetes
More informationRisk Factors for Heart Disease
Risk Factors for Heart Disease Risk Factors we cannot change (Age, Gender, Family History) Risk Factors we can change (modifiable) Smoking Blood pressure Cholesterol Diabetes Inactivity Overweight Stress
More informationFrequency of Metabolic Syndrome on Diabetes Mellitus Patients in Surabaya
Biomolecular and Health Science Journal Vol 1 No 1 (2018), April 2018 ORIGINAL ARTICLE Frequency of Metabolic Syndrome on Diabetes Mellitus Patients in Surabaya Dyah Peni Puspitasari 1, Budi Widodo 2,
More informationHypertension with Comorbidities Treatment of Metabolic Risk Factors in Children and Adolescents
Hypertension with Comorbidities Treatment of Metabolic Risk Factors in Children and Adolescents Stella Stabouli Ass. Professor Pediatrics 1 st Department of Pediatrics Hippocratio Hospital Evaluation of
More informationNutritional concerns of overweight / obese older persons. Gordon L Jensen, MD, PhD Dept Nutritional Sciences Penn State University
Nutritional concerns of overweight / obese older persons Gordon L Jensen, MD, PhD Dept Nutritional Sciences Penn State University Prevalence of obesity among older adults: NHANES 1999-2004 Sex Age (years)
More informationCardiorespiratory Fitness is Strongly Related to the Metabolic Syndrome in Adolescents. Queen s University Kingston, Ontario, Canada
Diabetes Care In Press, published online May 29, 2007 Cardiorespiratory Fitness is Strongly Related to the Metabolic Syndrome in Adolescents Received for publication 16 April 2007 and accepted in revised
More informationThe Impact of High Intensity Interval Training On Lipid Profile, Inflammatory Markers and Anthropometric Parameters in Inactive Women
Brief Report The Impact of High Intensity Interval Training On Lipid Profile, Inflammatory Markers and Anthropometric Parameters in Inactive Women Nasrin Zaer Ghodsi (MSc) Department of Physical Education,
More informationImpact of Physical Activity on Metabolic Change in Type 2 Diabetes Mellitus Patients
2012 International Conference on Life Science and Engineering IPCBEE vol.45 (2012) (2012) IACSIT Press, Singapore DOI: 10.7763/IPCBEE. 2012. V45. 14 Impact of Physical Activity on Metabolic Change in Type
More informationYour Name & Phone Number Here! Longevity Index
Your Name & Phone Number Here! Longevity Index Your Health Risk Analysis is based on a variety of medical and scientific data from organizations such as the American Heart Association, American Dietetic
More informationIn Europe, overweight and obesity are increasing rapidly in most. countries, and health economic consequences are now appearing.
1. Obesity in Europe In Europe, overweight and obesity are increasing rapidly in most countries, and health economic consequences are now appearing. An increase focus on this problem has lead to important
More informationALT and aspartate aminotransferase (AST) levels were measured using the α-ketoglutarate reaction (Roche,
Supplemental Methods Analytical determinations ALT and aspartate aminotransferase (AST) levels were measured using the α-ketoglutarate reaction (Roche, Basel, Switzerland). Glucose, triglyceride, total
More informationScience of Obesity (I-2.28)
Science of Obesity (I-2.28) Dr Noha Nooh Lasheen Lecturer of Physiology Date :16 / 10 / 2016 Objectives By the end of this lecture, the student should be able to: Define energy, energy balance and obesity.
More informationMacrovascular Disease in Diabetes
Macrovascular Disease in Diabetes William R. Hiatt, MD Professor of Medicine/Cardiology University of Colorado School of Medicine President, CPC Clinical Research Conflicts CPC Clinical Research (University-based
More informationADVANCED CARDIOMETABOLIC SCREENING
ADVANCED CARDIOMETABOLIC SCREENING INTRODUCTION SignatureMD and its affiliated physicians continuously seek out technology to identify health risk factors before they become serious diseases. SignatureMD
More informationPlasma fibrinogen level, BMI and lipid profile in type 2 diabetes mellitus with hypertension
World Journal of Pharmaceutical Sciences ISSN (Print): 2321-3310; ISSN (Online): 2321-3086 Published by Atom and Cell Publishers All Rights Reserved Available online at: http://www.wjpsonline.org/ Original
More informationTHE CLINICAL BIOCHEMISTRY OF LIPID DISORDERS
THE CLINICAL BIOCHEMISTRY OF LIPID DISORDERS Hormonal regulation INSULIN lipid synthesis, lipolysis CORTISOL lipolysis GLUCAGON lipolysis GROWTH HORMONE lipolysis CATECHOLAMINES lipolysis LEPTIN catabolism
More informationNEW CLINICAL GUIDELINES FOR THE MANAGEMENT OF OBESITY AND METABOLIC SYNDROME
NEW CLINICAL GUIDELINES FOR THE MANAGEMENT OF OBESITY AND METABOLIC SYNDROME Alexander Frame, Richard Mathias School of Population and Public Health Obesity Pandemic (WHO) Developed Nations Developing
More informationPredictive value of overweight in early detection of metabolic syndrome in schoolchildren
Predictive value of overweight in early detection of metabolic syndrome in schoolchildren Marjeta Majer, Vera Musil, Vesna Jureša, Sanja Musić Milanović, Saša Missoni University of Zagreb, School of Medicine,
More informationINSULIN RESISTANCE, POLYCYSTIC OVARIAN SYNDROME An Overview
INSULIN RESISTANCE, POLYCYSTIC OVARIAN SYNDROME An Overview University of PNG School of Medicine & Health Sciences Division of Basic Medical Sciences PBL MBBS III VJ Temple 1 Insulin Resistance: What is
More informationEffective Interventions in the Clinical Setting: Engaging and Empowering Patients. Michael J. Bloch, M.D. Doina Kulick, M.D.
Effective Interventions in the Clinical Setting: Engaging and Empowering Patients Michael J. Bloch, M.D. Doina Kulick, M.D. UNIVERSITY OF NEVADA SCHOOL of MEDICINE Sept. 8, 2011 Reality check: What could
More informationObesity in the pathogenesis of chronic disease
Portoroz October 16th 2013 Obesity in the pathogenesis of chronic disease Rocco Barazzoni University of Trieste Department of Medical, Surgical and Health Sciences Obesity Trends* Among U.S. Adults BRFSS,
More informationPrevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus patients in a tertiary care hospital of Bihar
Original Research Article Prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus patients in a tertiary care hospital of Bihar Naresh Kumar 1, Jyoti Kumar Dinkar 2*, Chandrakishore
More informationLIPID GUIDELINES: 2015
LIPID GUIDELINES: 2015 D P Mikhailidis BSc MSc MD FCPP FCP FRSPH FFPM FRCP FRCPath Academic Head Dept. of Clinical Biochemistry (Vascular Disease Prevention Clinics) Royal Free campus University College
More informationSelf-Efficacy, Decisional Balance and Stages of Change on Dietary Practices among Metabolic Syndrome Persons, Uthai Thani Province
Self-Efficacy, Decisional Balance and Stages of Change on Dietary Practices among Metabolic Syndrome Persons, Uthai Thani Province Manirat Therawiwat PhD*, Nirat Imamee PhD*, Thaweesak Khamklueng MSc**
More informationFructose, Uric Acid and Hypertension in Children and Adolescents
Fructose, Uric Acid and Hypertension in Children and Adolescents Daniel I. Feig, MD, PhD, MS Director, Division of Nephrology Department of Pediatrics University of Alabama, Birmingham Topics for Discussion
More information1Why lipids cannot be transported in blood alone? 2How we transport Fatty acids and steroid hormones?
1Why lipids cannot be transported in blood alone? 2How we transport Fatty acids and steroid hormones? 3How are dietary lipids transported? 4How lipids synthesized in the liver are transported? 5 Lipoprotien
More informationEpidemiology of Diabetes, Impaired Glucose Homeostasis and Cardiovascular Risk. Eberhard Standl
Epidemiology of Diabetes, Impaired Glucose Homeostasis and Cardiovascular Risk Eberhard Standl European Heart House Sophia Antipolis Thursday, June 17, 2010 IDF Diabetes Atlas 2009: Global Numbers Still
More informationRecognition of Reversible Liver Disease: A Window of Opportunity in the Metabolic Syndrome Epidemic
Recognition of Reversible Liver Disease: A Window of Opportunity in the Metabolic Syndrome Epidemic Harold T. Pretorius, M.D.,Ph.D,^ Alexander K. Antony, B.A. ^ Dennis E. Menke, A.A.,^ Nichole M. Richards,
More informationPIEDMONT ACCESS TO HEALTH SERVICES, INC. Guidelines for Screening and Management of Dyslipidemia
PIEDMONT ACCESS TO HEALTH SERVICES, INC. Policy Number: 01-09-021 SUBJECT: Guidelines for Screening and Management of Dyslipidemia EFFECTIVE DATE: 04/2008 REVIEWED/REVISED: 04/12/10, 03/17/2011, 4/10/2012,
More informationCRP and fibrinogen imply clinical outcome of patients with type-2 diabetes. and coronary artery disease
CRP and fibrinogen imply clinical outcome of patients with type-2 diabetes and coronary artery disease Marijan Bosevski 1, *, Golubinka Bosevska 1, Lily Stojanovska 2, Vasso Apostolopoulos 2, * 1 University
More informationIschemic Heart and Cerebrovascular Disease. Harold E. Lebovitz, MD, FACE Kathmandu November 2010
Ischemic Heart and Cerebrovascular Disease Harold E. Lebovitz, MD, FACE Kathmandu November 2010 Relationships Between Diabetes and Ischemic Heart Disease Risk of Cardiovascular Disease in Different Categories
More informationTest5, Here is Your My5 to Health Profile with Metabolic Syndrome Insight
Test5, Here is Your My5 to Health Profile with Metabolic Syndrome Insight Quest, Quest Diagnostics, the associated logo, and all associated Quest Diagnostics marks are the registered trademarks of Quest
More informationPREVALENCE OF METABOLIC SYNDROME AND ITS ASSOCIATED FACTORS IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER (MDD)
ORIGINAL ARTICLE PREVALENCE OF METABOLIC SYNDROME AND ITS ASSOCIATED FACTORS IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER Chawanun Charnsil, Sudrak Pilakanta, Suksiri Panikul Department of Psychiatry, Faculty
More informationSaturated Fat, Carbohydrates, & Metabolic Syndrome Should We Be Changing Our Recommendations? Presented by: Michael A.
Saturated Fat, Carbohydrates, & Metabolic Syndrome Should We Be Changing Our Recommendations? Presented by: Michael A. Roussell, PhD Mike Roussell, PhD Nutrition Consultant Author, 6 Pillars of Nutrition
More informationMore than We Bargained For: Metabolic Side Effects of Antipsychotic Medications
More than We Bargained For: Metabolic Side Effects of Antipsychotic Medications Michael D. Jibson, MD, PhD Professor of Psychiatry University of Michigan Disclosure In the past 12 months I have received
More informationMetabolic Syndrome in Asians
Metabolic Syndrome in Asians Alka Kanaya, MD Asst. Professor of Medicine, UCSF Asian CV Symposium, November 17, 2007 The Metabolic Syndrome Also known as: Syndrome X Insulin Resistance Syndrome The Deadly
More information2.5% of all deaths globally each year. 7th leading cause of death by % of people with diabetes live in low and middle income countries
Lipid Disorders in Diabetes (Diabetic Dyslipidemia) Khosrow Adeli PhD, FCACB, DABCC Head and Professor, Clinical Biochemistry, The Hospital for Sick Children, University it of Toronto Diabetes A Global
More informationModule 2: Metabolic Syndrome & Sarcopenia. Lori Kennedy Inc & Beyond
Module 2: Metabolic Syndrome & Sarcopenia 1 What You Will Learn Sarcopenia Metabolic Syndrome 2 Sarcopenia Term utilized to define the loss of muscle mass and strength that occurs with aging Progressive
More informationPREVALENCE OF METABOLİC SYNDROME İN CHİLDREN AND ADOLESCENTS
PREVALENCE OF METABOLİC SYNDROME İN CHİLDREN AND ADOLESCENTS Mehmet Emre Atabek,MD,PhD Necmettin Erbakan University Faculty of Medicine, Department of Pediatrics, Division of Pediatric Endocrinology and
More informationFructose in Insulin Resistance- Focused on Diabetes 순천향대학교부천병원 내분비내과 정찬희
Fructose in Insulin Resistance- Focused on Diabetes 순천향대학교부천병원 내분비내과 정찬희 Introduction Unique characteristics of Fructose Metabolism Mechanism for Fructose-Induced Insulin Resistance Epidemiological Studies
More informationRehabilitation and Research Training Center on Secondary Conditions in Individuals with SCI. James S. Krause, PhD
Disclosure The contents of this presentation were developed with support from educational grants from the Department of Education, NIDRR grant numbers H133B090005, H133B970011 and H133G010160. However,
More informationPart 1: Obesity. Dietary recommendations in Obesity, Hypertension, Hyperlipidemia, and Diabetes 10/15/2018. Objectives.
Dietary recommendations in Obesity, Hypertension, Hyperlipidemia, and Diabetes Stephen D. Sisson MD Objectives To review dietary recommendations in the following conditions: Obesity Hypertension Diabetes
More informationImproving Access to Quality Medical Care Webinar Series
Improving Access to Quality Medical Care Webinar Series Presented by The Arizona Telemedicine Program and the Southwest Telehealth Resource Center 2015 UA Board of Regents Welcome AZ, UT, CO, NM & NV FLEX
More information«Πατσζαρκία και Καρδιαγγειακή Νόζος»
«Πατσζαρκία και Καρδιαγγειακή Νόζος» Δημήτρης Π. Παπαδόπουλος-FESC Clinical Assist. Professor George Washington University USA Επιμελητής Καρδιολογικής Κλινικής Π.Γ.Ν.Α. «ΛΑΪΚΟ» Υπεύθυνος Αντιυπερτασικού
More informationMULTIFACTORIAL ANALYSIS OF CARDIOVASCULAR RISK FACTORS IN A GROUP OF PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
2014 ILEX PUBLISHING HOUSE, Bucharest, Roumania http://www.jrdiabet.ro Rom J Diabetes Nutr Metab Dis. 21(4):327-333 doi: 10.2478/rjdnmd-2014-0040 MULTIFACTORIAL ANALYSIS OF CARDIOVASCULAR RISK FACTORS
More informationFebruary 10, Division of Dockets Management HFA-305 Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD 20852
February 10, 2014 Division of Dockets Management HFA-305 Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD 20852 Re: Docket No. FDA-2013-N-1317 Dear Sir or Madam: The American Heart
More informationCardiovascular risk assessment in the metabolic syndrome: results from the Prospective Cardiovascular Munster (PROCAM) Study
(28) 32, S11 S16 & 28 Nature Publishing Group All rights reserved 37-6/8 $3. www.nature.com/ijo ORIGINAL ARTICLE Cardiovascular risk assessment in the metabolic syndrome: results from the Prospective Cardiovascular
More informationDiabetes and Heart Disease. Sarah Alexander, MD, FACC Assistant Professor of Medicine Rush University Medical Center
Diabetes and Heart Disease Sarah Alexander, MD, FACC Assistant Professor of Medicine Rush University Medical Center No conflicts of interest or financial relationships to disclose. 2 What s the problem??
More informationChapter 18. Diet and Health
Chapter 18 Diet and Health Risk Factors and Chronic Diseases Interrelationships among Chronic Diseases Chronic Disease Heart Disease and Stroke Hypertension Cancer Diabetes The Formation of Plaques in
More informationRoadmap. Diabetes and the Metabolic Syndrome in the Asian Population. Asian. subgroups 8.9. in U.S. (% of total
Diabetes and the Metabolic Syndrome in the Asian Population Alka Kanaya, MD Associate Professor of Medicine, UCSF Feb 26, 2010 Roadmap 1. Diabetes in Asian Americans Prevalence in the U.S. Risk factors
More informationChapter 2 The Metabolic Syndrome
Chapter 2 The Metabolic Syndrome Matthew J. Sorrentino Keywords Waist circumference Abdominal obesity Impaired fasting glucose HDL-cholesterol Triglycerides Metabolic syndrome is the designation given
More informationCardiometabolics in Children or Lipidology for Kids. Stanley J Goldberg MD Diplomate: American Board of Clinical Lipidology Tucson, Az
Cardiometabolics in Children or Lipidology for Kids Stanley J Goldberg MD Diplomate: American Board of Clinical Lipidology Tucson, Az No disclosures for this Presentation Death Risk Approximately 40% of
More informationMOLINA HEALTHCARE OF CALIFORNIA
MOLINA HEALTHCARE OF CALIFORNIA HIGH BLOOD CHOLESTEROL IN ADULTS GUIDELINE Molina Healthcare of California has adopted the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel
More informationLaboratory analysis of the obese child recommendations and discussion. MacKenzi Hillard May 4, 2011
Laboratory analysis of the obese child recommendations and discussion MacKenzi Hillard May 4, 2011 aka: What to do with Fasting Labs The Obesity Epidemic The prevalence of obesity in adolescents has tripled
More informationThe Metabolic Syndrome Maria Luz Fernandez, PhD
June 2007(II): S30 S34 The Metabolic Syndrome Maria Luz Fernandez, PhD The metabolic syndrome is a cluster of symptoms associated with insulin resistance and known to precede the onset of type 2 diabetes.
More informationCardiac Pathophysiology
Cardiac Pathophysiology Evaluation Components Medical history Physical examination Routine laboratory tests Optional tests Medical History Duration and classification of hypertension. Patient history of
More information2/11/2017. Weighing the Heavy Cardiovascular Burden of Obesity and the Obesity Paradox. Disclosures. Carl J. Lavie, MD, FACC, FACP, FCCP
Weighing the Heavy Cardiovascular Burden of Obesity and the Obesity Paradox Carl J. Lavie, MD, FACC, FACP, FCCP Professor of Medicine Medical Director, Cardiac Rehabilitation and Preventive Cardiology
More informationDavid Wright, MD Speaking of Women s Health Shawnee Mission Medical Center October 4, 2013
David Wright, MD Speaking of Women s Health Shawnee Mission Medical Center October 4, 2013 David Wright, MD October 4, 2013 Speaking of Women's Health 2 Weight Gain, Diabetes, Heart Disease Overweight
More informationOBESITY: The Growing Epidemic and its Medical Impact
OBESITY: The Growing Epidemic and its Medical Impact Ray Plodkowski, MD Co-Chief, Chief, of Division of Medical Nutrition, University of Nevada School of Medicine. Chief, Endocrinology & Metabolism, Sachiko
More informationCurrent Strategies in Breast Reconstruction
Current Strategies in Breast Reconstruction Hani Sbitany, MD Assistant Professor of Surgery University of California, San Francisco Division of Plastic and Reconstructive Surgery 12 th Annual School of
More informationThe promise of the thiazolidinediones in the management of type 2 diabetes-associated cardiovascular disease
The promise of the thiazolidinediones in the management of type 2 diabetes-associated cardiovascular disease Steve Smith, Group Director Scientific Affairs, Diabetes & Metabolism GlaxoSmithKline R & D
More information13/05/2013. Dairy Products: Pro- or Anti- Inflammatory Foods? An Overview. Inflammation. Adjusted relative risk of a first cardiovascular event
Relative risk* 13/05/2013 Dairy Products: Pro- or Anti- Inflammatory Foods? An Overview Marie-Ève Labonté, Patrick Couture, Benoît Lamarche INAF, Université Laval STELA Symposium 2013 Delta Centre-Ville,
More informationThe Metabolic Syndrome: Is It A Valid Concept? YES
The Metabolic Syndrome: Is It A Valid Concept? YES Congress on Diabetes and Cardiometabolic Health Boston, MA April 23, 2013 Edward S Horton, MD Joslin Diabetes Center Harvard Medical School Boston, MA
More informationChanges and clinical significance of serum vaspin levels in patients with type 2 diabetes
Changes and clinical significance of serum vaspin levels in patients with type 2 diabetes L. Yang*, S.J. Chen*, G.Y. Yuan, D. Wang and J.J. Chen Department of Endocrinology, Affiliated Hospital of Jiangsu
More informationAssociation between arterial stiffness and cardiovascular risk factors in a pediatric population
+ Association between arterial stiffness and cardiovascular risk factors in a pediatric population Maria Perticone Department of Experimental and Clinical Medicine University Magna Graecia of Catanzaro
More informationORIGINAL ARTICLE. Abstract. Introduction
ORIGINAL ARTICLE Health Education Hokenshido Program Reduced Metabolic Syndrome in the Amagasaki Visceral Fat Study. Three-Year Follow-up Study of 3,174 Japanese Employees Miwa Ryo 1, Tadashi Nakamura
More informationWelcome and Introduction
Welcome and Introduction This presentation will: Define obesity, prediabetes, and diabetes Discuss the diagnoses and management of obesity, prediabetes, and diabetes Explain the early risk factors for
More informationDietary recommendations in Obesity, Hypertension, Hyperlipidemia, and Diabetes. Stephen D. Sisson MD
Dietary recommendations in Obesity, Hypertension, Hyperlipidemia, and Diabetes Stephen D. Sisson MD Objectives To review dietary recommendations in the following conditions: Obesity Hypertension Diabetes
More informationShiftwork and cardiometabolic outcomes. Dr Anil Adisesh
Shiftwork and cardiometabolic outcomes Dr Anil Adisesh 1 FACULTY/PRESENTER DISCLOSURE Faculty: Dr Anil Adisesh Relationships with commercial interests: - None 2 Aims 1) Participants will be able to describe
More informationEnergy balance. Factors affecting energy input. Energy input vs. Energy output Balance Negative: weight loss Positive: weight gain
1 Energy balance Energy input vs. Energy output Balance Negative: weight loss Positive: weight gain Special implications Infancy, Illness, Pregnancy & Lactation, Sports Factors affecting energy input neuro-endocrine
More informationhttp://noodlemaz.wordpress.com/category/science/cancer/ Outline Introduction Serious nature of Cardiovascular Disease (CVD) How to prevent CVD? The disease process Damage and plaque development Current
More informationGuidelines on cardiovascular risk assessment and management
European Heart Journal Supplements (2005) 7 (Supplement L), L5 L10 doi:10.1093/eurheartj/sui079 Guidelines on cardiovascular risk assessment and management David A. Wood 1,2 * 1 Cardiovascular Medicine
More informationEmpower Preventive Medicine. Timothy J. McCormick, DO, MPH 4221 Baymeadows Suite 6 Jacksonville, FL
Empower Preventive Medicine Timothy J. McCormick, DO, MPH 4221 Baymeadows Suite 6 Jacksonville, FL 32217 904-367-4005 Drtim@emprevmed.com Obesity Medicine Old paradigm: Obesity was a matter of willpower,
More informationSleep and Weight Control
A Wake-up Call Charles H. Samuels, MD, CCFP, DABSM As presented at the Sleep and Respiration Rounds held at the Lung Association Sleep Centre at Foothills Medical Centre, Calgary, Alberta (May 2005) Jill
More informationAssociation of hypothyroidism with metabolic syndrome - A case- control study
Article ID: ISSN 2046-1690 Association of hypothyroidism with metabolic syndrome - A case- control study Peer review status: No Corresponding Author: Dr. Veena K Karanth, Associate Professor, Surgery,
More information